CAS |
No.1078166-57-0 |
英文名称 |
PF-04418948 |
别名 |
;UNII-I7Z38E70VF;PF-04418948; |
分子式 |
C23H20FNO5 |
分子量 |
409.41 |
溶解性 |
Soluble in DMSO |
纯度 |
≥98% |
外观(性状) |
White to off-white Solid |
储存条件 |
Powder:-20℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
运输条件 |
冷藏运输 |
MDL |
MFCD24387541 |
SMILES |
O=C(C1(COC2=CC=C3C=C(OC)C=CC3=C2)CN(C(C4=CC=C(F)C=C4)=O)C1)O |
InChIKey |
LWJGMYMNSNVCEM-UHFFFAOYSA-N |
InChI |
InChI=1S/C23H20FNO5/c1-29-19-8-4-17-11-20(9-5-16(17)10-19)30-14-23(22(27)28)12-25(13-23)21(26)15-2-6-18(24)7-3-15/h2-11H,12-14H2,1H3,(H,27,28) |
PubChem CID |
25114442 |
靶点 |
Prostaglandin Receptor |
通路 |
Endocrinology & Hormones;GPCR & G Protein |
背景说明 |
PF-04418948是一种新型有效的选择性前列腺素EP2受体拮抗剂。 |
生物活性 |
PF-04418948 is an orally active, potent and selective prostaglandin EP2 receptor antagonist with an IC50 of 16 nM[1]. |
In Vitro |
PF-04418948 (2 μM; 90 min) inhibits prostaglandin E2 (PGE2)-induced increase in cAMP[1]. |
In Vivo |
In dog bronchiole and mouse trachea, PF-04418948 produced parallel rightward shifts of the PGE(2)-induced relaxation curve with a K(B) of 2.5 nM and an apparent K(B) of 1.3 nM respectively. Reversal of the PGE(2)-induced relaxation in the mouse trachea by PF-04418948 produced an IC(50) value of 2.7 nM. Given orally, PF-04418948 attenuated the butaprost-induced cutaneous blood flow response in rats.[1]. |
动物实验 |
PF-04418948 (oral gavage; 1, 3, and 10 mg/kg; once) attenuats the butaprost-induced cutaneous blood flow response[1]. |
数据来源文献 |
[1]. af Forselles KJ, et al. In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist. Br J Pharmacol. 2011 Dec;164(7):1847-1856. |
规格 |
5mg 10mg 25mg 50mg 100mg |
单位 |
瓶 |